Drawing for HAP

USPTO serial 76285208

HAP

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
GAYNOR, BARBARA ANNE
Law office
DIVISIONAL UNIT

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HAP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Matthew M. Catlett

MATTHEW M CATLETT GENAISSANCE PHARMACEUTICALSFIVE SCIENCE PARKNEW HAVEN, CT 06511UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Biogenetic materials, namely, nucleic acids for use in the field of pharmaceutical clinical development and scientific researchACTIVE
005Biogenetic materials, namely, nucleic acids for use in the field of medical and clinical diagnosticsACTIVE
042Scientific and laboratory research, consulting in the fields of genomics, pharmaceutical clinical development and therapeutics, genetics and diagnosticsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 27, 2005MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 27, 2005ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 18, 2004EX4GSOU EXTENSION 4 GRANTED
Aug 27, 2004EXT4SOU EXTENSION 4 FILED
Aug 27, 2004FAXXFAX RECEIVED
Jul 30, 2004CFITCASE FILE IN TICRS
Apr 28, 2004EX3GSOU EXTENSION 3 GRANTED
Feb 27, 2004EXT3SOU EXTENSION 3 FILED
Feb 27, 2004FAXXFAX RECEIVED
Sep 6, 2003DPCCDIVISIONAL PROCESSING COMPLETE
Sep 5, 2003EX2GSOU EXTENSION 2 GRANTED
Aug 27, 2003EXT2SOU EXTENSION 2 FILED
Aug 27, 2003DRRRDIVISIONAL REQUEST RECEIVED
Aug 27, 2003FAXXFAX RECEIVED
May 10, 2003EX1GSOU EXTENSION 1 GRANTED
Feb 21, 2003MAILPAPER RECEIVED
Feb 19, 2003EXT1SOU EXTENSION 1 FILED
Aug 27, 2002NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 4, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 15, 2002NPUBNOTICE OF PUBLICATION
Mar 10, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Dec 19, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 17, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 30, 2001DOCKASSIGNED TO EXAMINER
Aug 29, 2001DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance